|
|
Blood, 1 November 2005, Vol. 106, No. 9, pp. 3068-3073.
Prepublished online as a Blood First Edition Paper on July 14, 2005; DOI 10.1182/blood-2005-04-1531.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy
Lequn Li,
Wayne R. Godfrey,
Stephen B. Porter,
Ying Ge,
Carle H. June,
Bruce R. Blazar, and
Vassiliki A. Boussiotis
From the Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; the Department of Pediatrics, University of Minnesota Cancer Center, Division of Hematology, Oncology and Transplantation, Minneapolis, MN; and the Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, Philadelphia, PA.
CD4+CD25+ regulatory T cells (Tregs) are essential negative regulators of immune responses. Here, we examined the signaling properties of human Tregs, using CD4+CD25+ Treg and CD4+CD25– control (Tcont) cell lines generated from cord blood. Treg cell lines were markedly hyporesponsive to stimulation with dendritic cells and with anti-CD3/CD28–coated beads. Hyporesponsiveness was reversed by exogenous interleukin-2 (IL-2). T-cell receptor (TCR)–CD3/CD28–mediated activation of Rap1 and Akt was retained in Tregs, but activation of Ras, mitogenactivated protein kinase 1/2 (MEK1/2), and extracellular signal-regulated kinase 1/2 (Erk1/2) was impaired. Tregs were blocked from cell cycle progression due to decrease of cyclin E and cyclin A and increase of p27kip1 (p27kip cyclin dependent kinase inhibitor). IL-2 induced sustained increase of cyclin E and cyclin A and prevented up-regulation of p27kip1. Tregs had high susceptibility to apoptosis that was reversed by IL-2, which correlated with activation of Erk1/2, up-regulation of Bcl-xL (B-cell CLL/lymphoma 2-like nuclear gene encoding mitochondrial protein, transcript variant 2), and phosphorylation of Bad (Bcl2 antagonist of cell death) at Ser112. Thus, Tregs share biochemical characteristics of anergy, including abortive activation of Ras-MEK-Erk, increased activation of Rap1, and increased expression of p27kip1. In addition, our results indicate that TCR–CD3/CD28–mediated and IL-2 receptor–mediated signals converge at the level of MEK-Erk kinases to regulate Treg survival and expansion and suggest that manipulation of the MEK-Erk axis may represent a novel strategy for Treg expansion for immunotherapy.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
B. Kavanagh, S. O'Brien, D. Lee, Y. Hou, V. Weinberg, B. Rini, J. P. Allison, E. J. Small, and L. Fong
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
Blood,
August 15, 2008;
112(4):
1175 - 1183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Muzio, B. Apollonio, C. Scielzo, M. Frenquelli, I. Vandoni, V. Boussiotis, F. Caligaris-Cappio, and P. Ghia
Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy
Blood,
July 1, 2008;
112(1):
188 - 195.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Morton, B. McManus, P. Garside, A. McI. Mowat, and M. M. Harnett
Inverse Rap1 and Phospho-ERK Expression Discriminate the Maintenance Phase of Tolerance and Priming of Antigen-Specific CD4+ T Cells In Vitro and In Vivo
J. Immunol.,
December 15, 2007;
179(12):
8026 - 8034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Yates, F. Rovis, P. Mitchell, B. Afzali, J.-S Tsang, M. Garin, R. Lechler, G. Lombardi, and O. Garden
The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro
Int. Immunol.,
June 1, 2007;
19(6):
785 - 799.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Gonzalez, E. Tamayo, I. Santiuste, R. Marquina, L. Buelta, M. A. Gonzalez-Gay, S. Izui, M. Lopez-Hoyos, J. Merino, and R. Merino
CD4+CD25+ T Cell-Dependent Inhibition of Autoimmunity in Transgenic Mice Overexpressing Human Bcl-2 in T Lymphocytes
J. Immunol.,
March 1, 2007;
178(5):
2778 - 2786.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. K. Crellin, R. V. Garcia, and M. K. Levings
Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells
Blood,
March 1, 2007;
109(5):
2014 - 2022.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Nilsson, A. Boasso, P. A. Velilla, R. Zhang, M. Vaccari, G. Franchini, G. M. Shearer, J. Andersson, and C. Chougnet
HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS
Blood,
December 1, 2006;
108(12):
3808 - 3817.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. C. Jury, D. A. Isenberg, C. Mauri, and M. R. Ehrenstein
Atorvastatin Restores Lck Expression and Lipid Raft-Associated Signaling in T Cells from Patients with Systemic Lupus Erythematosus
J. Immunol.,
November 15, 2006;
177(10):
7416 - 7422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Hickman, J. Yang, R. M. Thomas, A. D. Wells, and L. A. Turka
Defective Activation of Protein Kinase C and Ras-ERK Pathways Limits IL-2 Production and Proliferation by CD4+CD25+ Regulatory T Cells
J. Immunol.,
August 15, 2006;
177(4):
2186 - 2194.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Y.-S. Tsang, N. O. S. Camara, E. Eren, H. Schneider, C. Rudd, G. Lombardi, and R. Lechler
Altered proximal T cell receptor (TCR) signaling in human CD4+CD25+ regulatory T cells
J. Leukoc. Biol.,
July 1, 2006;
80(1):
145 - 151.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
